SCHEDULE 13G

Cumberland Pharmaceuticals, Inc.

Common Stock, no par value · CUSIP: 230770109

Event date: 2025-02-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Integrated Core Strategies (US) LLC

  Shares: 1,229,557.00 · Class: 8.8%

• Millennium Management LLC

  Shares: 1,229,633.00 · Class: 8.8%

• Millennium Group Management LLC

  Shares: 1,229,633.00 · Class: 8.8%

• Israel A. Englander

  Shares: 1,229,633.00 · Class: 8.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.